Tamtam Try Tamtam free
SelectQuote Insurance Services logo

SelectQuote Insurance Services account plan

Comparing insurance quotes

At a glance

SelectQuote is a US direct-to-consumer platform for Medicare, life insurance and pharmacy services, with FY2026 revenue of $1,618.5 million.

SelectQuote, based in Overland Park, Kansas and listed on the NYSE as SLQT, is a technology-enabled, direct-to-consumer distribution platform for insurance policies and healthcare services. It sells Medicare, life and auto and home policies from carrier partners through licensed agents, earning commissions without underwriting risk, and runs the SelectRx pharmacy for seniors. In FY2026 (year ended June 30, 2026) total revenue was $1,618.5 million (+6%), of which Pharmacy was 51%, with net income of $62.2 million and Adjusted EBITDA of $109.1 million. At June 30, 2026 it had 1,098 agents and 2,941 non-agent full-time equivalent employees.

Business units

Strategic priorities

Cash flow and deleveraging
Management targets at least $60 million of operating cash flow in fiscal 2027 and free cash flow of around $50 million, with cash used to reduce high-cost debt and eventually pay the preferred dividend in cash.
Double Healthcare Services margins
Healthcare Services margins are expected to approximately double in fiscal 2027, helped by a new pharmacy management system and moving more prescriptions to the Olathe, Kansas facility; the long-term target is low double-digit EBITDA margins.
AI in the contact center
More than $30 million of run-rate costs were removed, mostly through technology: more than 1/3 of incoming calls are screened and routed with AI, and a voice AI enrollment agent handles formal enrollment during AEP.
Profitable Senior production
The company keeps Senior Adjusted EBITDA margins above its 20% target, with a smaller, tenured agent force and the aim of beating last year's 30% recapture rate during AEP.
Cross-sell into Healthcare Services and Life
The Senior database is used to acquire Healthcare Services consumers, and final expense benefits from transfers from Senior at no incremental acquisition cost.

Latest results

In fiscal Q1 2027 (three months to September 30, 2026), the seasonal low before AEP, revenue fell 15% to $280.0 million, but the net loss narrowed to $20.3 million from $30.5 million and Adjusted EBITDA improved to -$17.0 million from -$32.1 million. Senior approved policies fell 22% while MA LTV per approved policy rose 16% to $890; Healthcare Services revenue fell 16% but its Adjusted EBITDA rose to $11.2 million. Marketing and advertising was cut 25%. Fiscal 2027 guidance is revenue of $1.35 billion to $1.45 billion and Adjusted EBITDA of $90 million to $115 million.

Investments and deals

Olathe, Kansas fulfillment facility
The 54,000 sq ft SelectRx facility opened in April 2025 and runs about 30% more efficiently than legacy sites; fewer than 20% of prescriptions ship from it today.
New credit facility
On January 8, 2026 a $325.0 million term loan maturing January 8, 2031 and a revolver of up to $90.0 million replaced the 2019 facility.
Preferred stock
$350.0 million of Senior Non-Convertible Preferred Stock was issued in February 2025 to Morgan Stanley and Bain Capital affiliates, with dividends accruing at 14.5% per annum.
AI programme
AI investments began in FY2026: contact center voice AI, AI-assisted software development and enterprise productivity tools, plus a custom-built pharmacy management system.

Challenges and risks

Carrier concentration and MA disruption
UHC, Humana and Aetna entities accounted for 39%, 13% and 12% of FY2026 revenue, and carriers keep refining plan features, with MA approved policies expected to decline 10% to 15% in fiscal 2027.
Inflation Reduction Act pressure on pharmacy
Inflation Reduction Act manufacturer refunds reduce SelectRx revenue, and Healthcare Services revenue is guided down 10% to 15% in fiscal 2027.
Leverage
Debt and preferred equity total around $800 million at a cost of approximately 12%; total debt obligations were $385.8 million at September 30, 2026 against $14.3 million of cash and restricted cash.
DOJ False Claims Act action
The DOJ partially intervened on May 1, 2025 in a qui tam action; motions to dismiss were largely denied on March 26, 2026, and an adverse outcome could limit marketing development funds.
NYSE listing
A notice received on March 19, 2026 for a share price below $1.00 led the company to seek a reverse stock split to remain listed.

What leadership says

“we believe we are nearing an inflection point for the Medicare Advantage industry”

Timothy Danker, Chief Executive Officer · SelectQuote fiscal Q1 2027 earnings call, November 4, 2026

“These tools do not replace our licensed agents.”

Timothy Danker, Chief Executive Officer · On voice AI, SelectQuote fiscal Q1 2027 earnings call, November 4, 2026

“we see a wide disconnect in the value of our shares relative to the real cash flow generation of our platform.”

Timothy Danker, Chief Executive Officer · SelectQuote fiscal Q4 2026 earnings call, August 25, 2026

“we are not raising capital.”

Ryan Clement, Chief Financial Officer · On the reverse stock split, SelectQuote fiscal Q1 2027 earnings call, November 4, 2026

Where a supplier can help

Contact center AI
Tied to the AI in the contact center priority: voice AI, call analytics and agent-assist vendors can extend call screening and enrollment automation beyond the third of calls already covered.
Pharmacy automation and logistics
Tied to the goal of doubling Healthcare Services margins: fulfillment automation, packaging and shipping partners can help move more prescriptions to the more efficient Olathe facility.
Lead generation and marketing efficiency
Tied to the cash flow priority and the 25% marketing cut: data and direct marketing suppliers that lower cost per lead fit the shift to its own direct marketing channels.
Compliance tooling
Tied to the DOJ action and CMS marketing rules: call recording, consent and quality assurance tools help document compliant Medicare sales.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like SelectQuote Insurance Services?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about SelectQuote Insurance Services

What does SelectQuote do?

SelectQuote sells Medicare, life and auto and home insurance from carrier partners through licensed agents and earns commissions without underwriting risk. It also runs the SelectRx pharmacy and other healthcare services for seniors.

What is SelectQuote's revenue?

FY2026 (year ended June 30, 2026) total revenue was $1,618.5 million, up 6%, with net income of $62.2 million. Fiscal 2027 guidance is $1.35 billion to $1.45 billion.

How many employees does SelectQuote have?

At June 30, 2026 it had 1,098 agents and 2,941 non-agent full-time equivalent employees.

Who leads SelectQuote?

Timothy Danker is CEO and Ryan Clement is CFO; Bob Grant is President.

What is SelectQuote's strategy?

It prioritises cash flow and deleveraging, keeps Senior profitable with a smaller tenured agent force, grows Healthcare Services margins, and uses AI to cut contact center costs.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)